Affiliation:
1. Department of Pharmacology, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, MI 48105, USA
Abstract
Abstract
The practical use of many adenosine receptor antagonists is limited by poor aqueous solubility. In some cases, solubilities are so low that they are difficult to measure by conventional means. To determine solubilities of adenosine antagonists, a sensitive radioreceptor method has been developed. Solubilities in Tris buffer (pH 7·7) ranged from 141 nM for 8−(2−amino−4−hlorophenyl)−1,3−dipropylxanthine to 945 μM for the amino-substituted xanthine PD 113,297. Ratios between solubility and adenosine receptor affinity varied from 15·8 for the A2-selective antagonist HTQZ to 169 000 for PD 113,297. From literature data on functional activity, it is apparent that useful adenosine antagonist activity in-vivo is only seen in compounds with solubility/affinity ratios greater than 100.
Publisher
Oxford University Press (OUP)
Subject
Pharmaceutical Science,Pharmacology
Reference31 articles.
1. Adenosine antagonism by purines, pteridines, and benzopteridines in human fibroblasts;Bruns;Biochem. Pharmacol.,1981
2. Adenosine and xanthines;Bruns,1987
3. New non-xanthine adenosine antagonists;Bruns;Pharmacologist,1987
4. 6-Arylpyrazolo[3,4-d]pyrimidines with high affinity in adenosine A1 and A2 binding;Bruns;Fed. Proc.,1987
5. Adenosine receptor binding. Structure-activity analysis generates extremely potent xanthine antagonists;Bruns;Proc. Natl. Acad. Sci.,1983
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献